Exhibition / Event Schedule

Day 1

12:45 – Participant Login & Networking
13:00 – Welcome Remarks
13:20 – Introduction to Immunogenicity and ADA Concepts
14:45 – Immunogenicity Risk Assessment, Mitigation & Development Strategies
16:15 – Preclinical Study Design and Bioanalytical Detection Methods
17:30 – Discussion Session
18:00 – End of Day 1

Day 2

13:00 – Analytical Assay Development for Immunogenicity Assessment
14:35 – Regulatory and Quality Requirements for Immunogenicity
16:00 – Clinical Development Challenges and ADA Risk Management
17:20 – Case Studies, Practical Recommendations & Q&A
17:50 – Wrap-Up and Key Takeaways
18:00 – End of Training